Overview
P95 offers full-service CRO clinical trial solutions. The company specializes in epidemiology and real-world evidence for vaccines and infectious diseases.
Key people
In the news
- Presented at the #ERSCongress 2026, this poster explores the demographic and clinical characteristics, treatment patterns, and outcomes of adults hospitalized with severe acute respiratory infection (SARI) across Europe. Drawing on data from more than 7,700 medically vulnerable adults enrolled through the id.DRIVE Network, the analysis compares patients hospitalized with influenza, respiratory syncytial virus (RSV), SARS-CoV-2, and other respiratory infections. The findings highlight important differences in patient risk profiles,
- When studies fall behind, rapid action matters. Download our Rescue Study Experience Fact Sheet to learn how we've helped sponsors improve enrollment, resolve operational challenges, and keep development programs moving forward.
- The science of vaccines is global, but the delivery is profoundly local. Successful execution requires understanding far more than protocol requirements. It means engaging with: • Key opinion leaders • Trusted local voices • Public health systems • Local communication channels 👉 Talk with one of our Africa experts today: https://lnkd.in/dqczwFdM #Vaccines #Africa #PatientEngagement #ClinicalResearch
- Pharmacoepidemiology is playing an increasingly important role in how researchers, regulators, and life science companies answer complex questions about medicines beyond traditional clinical trial settings. In our latest article, the P95 Julius Clinical team shares key takeaways from #ISPEAnnual2026, including real-world evidence, methodological precision, AI, and more representative research Read the article: https://lnkd.in/enAQez-X
- How can public-private partnerships strengthen real-world evidence generation? Our newly published commentary in Clinical Microbiology and Infection highlights how id.DRIVE generates real-world evidence in infectious diseases and vaccines, highlighting the benefits and challenges of the Public-Private governance model. By bringing together public and private partners, id.DRIVE supports observational studies and post-marketing evaluations. In a complex landscape, the id.DRIVE partnership occupies a distinct position in vaccine
- The European Respiratory Society Congress is in full swing, and our team is thrilled to be here! We are enjoying the opportunity to connect with peers, exchange ideas, and be part of the conversations advancing respiratory research. #ERSCongress #Respiratory #Research | Edgar Viles i Lladó, Omar Koussa, Leyla Kragten-Tabatabaie
- As clinical research expands across countries and regions, quality systems cannot remain static. Successful vaccine programs require: ✔ Centralized oversight ✔ Standardized SOPs ✔ Unified training ✔ Structured medical and safety oversight ✔ Dynamic local execution As Jeanelle de Villiers quotes, "Global standards paired with local execution. Not one replacing the other. Inspection readiness cannot be episodic." 🔗Learn more about our Africa expertise: https://lnkd.in/dqczwFdM #Africa #QualityManagement #ClinicalResearch
- We're #hiring a new Clinical Research Associate Germany (remote, 0.8-1.0 FTE) in Germany. Apply today or share this post with your network.
Alumni 2 went on to found or lead
Gautier SobczakBusiness Developer - EMEA→Co-Founder & Chief Business Officer at MyData-TRUST - Data Protection & Privacy for Life Sciences
Sebastien GrauweMember of the Board of Advisors→Founder at Herontrack
Thomas VerstraetenCEO & Founder
Related profiles
Something wrong or missing? Send an update. Fixed within 24 hours.